PramlintideWeight LossSafety Rating 8/10
Primary research areaAdjunct therapy for type 1 and 2 diabetes
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range15-60 mcg before meals (T1D); 60-120 mcg before meals (T2D)
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Symlin)
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Pramlintide
Mechanism of action
Amylin analog; slows gastric emptying, reduces glucagon, increases satiety
Safety profile
Nausea, hypoglycemia when combined with insulin · Approved for diabetes; hypoglycemia risk (black box); nausea; requires careful dosing but manageable
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Pramlintide below your target.
Related pages